Samsung recognizes Española Valley High School for innovative Parkinson’s Disease project
Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease. Students, in coordination with ...
Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Red flags of Parkinson's disease as mum is diagnosed at just 28 years old
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
The Forward1d
How one Jewish geneticist turned a family tragedy into a lifesaving mission.
February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.
Gain Therapeutics CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...
Ozzy Osbourne to reunite with Black Sabbath bandmates in Birmingham for 'greatest' show ever
Ozzy Osbourne will reunite with all of the original members of Black Sabbath for the first time in 20 years, in a gig that ...
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...
Sharon Osbourne says ‘it’s time for Ozzy Osbourne to say good night’ with final gig
Black Sabbath have announced their final ever show with vocalist Ozzy Osbourne will take place this summer, marking the first ...
News Medical3d
GLP-1 drug exenatide shows no benefit for Parkinson's in new study
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.
News Medical4d
Innovative 3D blood-brain barrier model enhances understanding of neuroinflammation
A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of ...
Compound with neuroprotective properties shows promise for Parkinson's treatment
A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...
Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial
JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...